Skip to content

Jocelyn A. Ricard

3 papers in the library · 68 citations · publishing 2022-2024

Papers

Sort Most recent Most cited

Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension

Frontiers in Psychiatry June 24, 2024 Grant Jones, Jocelyn A. Ricard, Matthew K. Nock 5 citations

Background Hypertension is a major source of morbidity and mortality worldwide, particularly for racial and ethnic minorities who face higher rates of hypertension and worse health-related outcomes. Recent research has reported on protective associations between classic psychedelics and hypertension; however, there is a need to explore how race and ethnicity may moderate such associations....

Associations between MDMA/ecstasy use and physical health in a U.S. population-based survey sample

Journal of Psychopharmacology October 1, 2022 Grant Jones, Jocelyn A. Ricard, Peter S. Hendricks et al. 7 citations

INTRODUCTION: 3,4-Methylenedioxymethamphetamine (MDMA/"ecstasy") is an empathogen that can give rise to increased pleasure and empathy and may effectively treat post-traumatic stress disorder. Although prior research has demonstrated associations between ecstasy use and favorable mental health outcomes, the associations between ecstasy and physical health have largely been unexplored. Thus, the...

Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample

Scientific Reports April 7, 2022 Grant Jones, Jocelyn A. Ricard, Joshua Lipson et al. 56 citations

Abstract Opioid use disorder (OUD) is a major source of morbidity and mortality in the U.S. and there is a pressing need to identify additional treatments for the disorder. Classic psychedelics (psilocybin, peyote, mescaline, LSD) have been linked to the alleviation of various substance use disorders and may hold promise as potential treatments for OUD. The aim of this study was to assess...